Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2024-06-07 00:00:00 ET · period of report 2024-06-05 · accession 0000875320-24-000172 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-06-07 | 2024-06-05 | VRTX | Sachdev Amit | EVP Chief Patient, Ext Af Off | G - Gift | $0.00 | -4,600 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-05 | G | D | 4,600 | $0.00 | 0 | I Held in Trust | — | — |